| Primary information |
|---|
| ID | antitb_1229, |
| Name | 23993672 |
| N-Terminal modification | High Activity Binding Peptides (HABPs) |
| C-Terminal Modification | AVALGLASPADAAAGTMYGD |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | None |
| Chirality | Linear |
| Nature | 20 |
| Source | L |
| Species | Protein Derived |
| Strain | From Rv1268c protein |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
| Inhibition Concentration | In vitro |
| Sequence | 2013 |
| Cytotoxicity | U937 monocyte derived macrophages (ATCC No. CRL-1593.2) |
| In vivo Model | Inhibited mycobacterial entry by up to 65%. |
| Lethal Dose | NA |
| Immune Responce | None |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | Inhibit mycobacterial entry into cells |
| Other activities | NA |
| PMID | None |
| Year of Publication | None |
Tertiary Structure
(Technique) | Not Predicted), |